Pazopanib (P) and cisplatin (CDDP) in patients with advanced solid tumors: A UNICANCER phase I study.

被引：2
|
作者：
Dieras, Veronique
Bachelot, Thomas
Campone, Mario
Isambert, Nicolas
Joly, Florence
Le Toumeau, Chrlstophe
Cassler, Philippe Alexandre
Bompas, Emmanuelle
Fumoloau, Pierre
Noal, Sabine
Orsini, Christina
Jimenez, Marta
Imbs, Diane Charlotte
Chatelut, Etienne
机构：
[1] Inst Curie, Paris, France
[2] Ctr Leon Berard, F-69373 Lyon, France
[3] Inst Cancerol Ouest, Nantes, France
[4] Ctr Georges Francois Leclerc, Dijon, France
[5] Ctr Francois Baclesse, Dept Med Oncol, F-14021 Caen, France
[6] Inst Curie, Dept Med Oncol, Paris, France
[7] Inst Cancerol Ouest, Dept Med Oncol, Nantes, France
[8] Ctr Francois Baclesse, F-14021 Caen, France
[9] UNICANCER, Paris, France
[10] Inst Claudius Regaud, Toulouse, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.2583
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2583
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PHASE I STUDY OF AMATUXIMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
    Fujisaka, Y.
    Kurata, T.
    Tanaka, K.
    Kudo, T.
    Okamoto, K.
    Tsurutani, J.
    Kaneda, H.
    Kitamura, C.
    Namiki, M.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2013, 24
  • [42] Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
    Lockhart, Albert C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [43] Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors
    Duran, I
    Siu, LL
    Chen, EX
    Oza, AM
    Sturgeon, J
    Chin, SF
    Brown, S
    Pond, GR
    Nottage, M
    ANTI-CANCER DRUGS, 2006, 17 (01) : 81 - 87
  • [44] Phase I and pharmacokinetic trial of the antitemolerase agent KML001 (KML) and cisplatin (CDDP) in advanced solid tumors.
    Edelman, Martin J.
    Feliciano, Josephine Louella
    Styblo, Miroslav
    Liu, Tao
    Lapidus, Rena G.
    Saunders, Jesse
    Gobburu, Joga
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Cisplatin-paclitaxel weekly schedule in advanced solid tumors: A phase I study
    Frasci, G
    Comella, P
    Parziale, A
    Casaretti, R
    Daponte, A
    Gravina, A
    DeRosa, L
    Gallipoli, A
    Comella, G
    ANNALS OF ONCOLOGY, 1997, 8 (03) : 291 - 293
  • [46] Pharmacokinetics (PK) and efficacy of S-1 plus cisplatin (CDDP) in patients with advanced gastric cancer (GC): A phase I/II study.
    Koizumi, W
    Tanabe, S
    Saigenji, K
    Ohtsu, A
    Boku, N
    Nagashima, F
    Muto, M
    CLINICAL CANCER RESEARCH, 2000, 6 : 4573S - 4574S
  • [47] Phase I and Pharmacokinetic (PK) Study of Pazopanib in Combination with Two Schedules of Docetaxel (D) in Patients (pts) with Advanced Solid Tumors
    Hamberg, P.
    Mathijssen, R. H.
    de Bruijn, P.
    van der Biessen, D.
    Loos, W. J.
    Sleijfer, S.
    Verweij, J.
    de Jonge, M. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 177 - 177
  • [48] Ongoing phase I study of pemetrexed combined with gemcitabine and cisplatin in patients with locally advanced or metastatic solid tumors
    Boiling, Claus
    Luebbing, Corinna
    Graefe, Tobias
    Fleeth, Jochen
    von Scheel, Jobst
    Luedtke, Frank E.
    Mueller-Hagen, Sigrun
    Depenbrock, Henrik
    Ohnmacht, Ute
    Hanauske, Axel-R
    ANNALS OF ONCOLOGY, 2004, 15 : 104 - 104
  • [49] Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors
    Lockhart, A. Craig
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Wang-Gillam, Andrea
    Moseley, Jennifer L.
    Barber, Stephanie L.
    Lane, Alex R.
    Wack, Claudine
    Kassalow, Laurent
    Dedieu, Jean-Francois
    Mita, Alain C.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (06) : 1236 - 1245
  • [50] Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors
    Saltz, LB
    Spriggs, D
    Schaaf, LJ
    Schwartz, GK
    Ilson, D
    Kemeny, N
    Kanowitz, J
    Steger, C
    Eng, M
    Albanese, P
    Semple, D
    Hanover, CK
    Elfring, GL
    Miller, LL
    Kelsen, D
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3858 - 3865
12345